Evaluation of anti-Pneumocystis agents using flow cytometry.
Morley
P J
PJ
Dept. Chemotherapy, Glaxo Research and Development Limited, Greenford, Middlesex, UK.
Dash
L
L
Jackson
H C
HC
D000818:Animals; D000935:Antifungal Agents / Q000494:pharmacology*; D002176:Candida albicans / Q000302:isolation & purification; D004353:Drug Evaluation, Preclinical / Q000379:methods; D005069:Evaluation Studies as Topic; D005434:Flow Cytometry / Q000379:methods*; D066298:In Vitro Techniques; D008297:Male; D008826:Microbial Sensitivity Tests; D009172:Mycology / Q000379:methods; D009894:Opportunistic Infections / Q000382:microbiology; D011010:Pneumocystis / Q000187:drug effects* / Q000302:isolation & purification; D011020:Pneumonia, Pneumocystis / Q000382:microbiology; D051381:Rats; D017207:Rats, Sprague-Dawley
D000935:Antifungal Agents